VistaGen’s nasal spray could reduce menopausal hot flashes, new data suggests
In new Phase IIa data, VistaGen's nasal spray reduced the average number of hot flashes in women with menopause.
IDE clinical trial for artificial cervical disc completes enrollment
FogPharma doses first patient in colorectal cancer drug trial
ASCO 2023: AstraZeneca’s PD-1/TIGIT shows promise in checkpoint-exposed NSCLC
ASCO 2023: Precigen reports positive early data for CAR-T therapy
ANeuroTech receives FDA approval for Phase IIIb MDD drug trial
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreCocrystal receives approval from HREC for Phase I trial of Covid-19 therapy
CDI-988 demonstrated in vitro potency against SARS-CoV-2 and other coronaviruses.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
The future of long Covid trials
Sinovac Biotech gets approval for clinical trial of Covid-19 injection
Role of machine learning tools in early diagnosis of Parkinson’s disease
Shionogi starts Phase I trial of Covid-19 antiviral in Japan